A prometabolite strategy inhibits cardiometabolic disease in an ApoE–/– murine model of atherosclerosis
Butyrate, a microbiome-derived short-chain fatty acid with pleiotropic effects on inflammation and metabolism, has been shown to significantly reduce atherosclerotic lesions, rectify routine metabolic parameters such as low-density lipoprotein cholesterol (LDL-C), and reduce systemic inflammation in...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical investigation
2025-08-01
|
| Serier: | JCI Insight |
| Fag: | |
| Online adgang: | https://doi.org/10.1172/jci.insight.191090 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
